Brief: Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes
24/09/2026 12:09
BRIEF-Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes Sept 24 (Reuters) - Viking Therapeutics, Inc. VKTX.O:
VIKING THERAPEUTICS PRICES UPSIZED $500 MILLION OFFERING OF COMMON STOCK AND CONVERTIBLE SENIOR NOTES
VIKING THERAPEUTICS, - OFFERING SIZE INCREASED TO $275 MILLION COMMON STOCK AND $225 MILLION NOTES
Source text: ID:nPn4BsjLba
Further company coverage: VKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viking Therapeutics
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry